Form D · Biotechnology
Oncocyte Corp
Irvine, CA · CIK 0001642380
Offering snapshot reported Feb 24, 2025 · SEC filing
- Reported sold
- $21.7M Offering amount: $21.7M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 10, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 24, 2025 | Initial | $21,743,597 | No comparison | 12 | SEC filing |
| Oct 8, 2024 | Initial | $10,204,262 | No comparison | 16 | SEC filing |
| Apr 25, 2024 | Initial | $15,807,692 | No comparison | 21 | SEC filing |
| Apr 29, 2021 | Initial | $3,006,577 | No comparison | Not reported | SEC filing |
| Mar 8, 2021 | Initial | $5,000,000 | No comparison | 7 | SEC filing |
| Feb 11, 2020 | Initial | $5,000,000 | No comparison | 29 | SEC filing |
| Sep 9, 2016 | Initial | $10,549,997 | No comparison | 9 | SEC filing |
| Oct 15, 2015 | Initial | $8,349,439 | No comparison | 1 | SEC filing |
| May 14, 2015 | Initial | $3,300,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-539015
The Company did not engage a placement agent.
Source: Form D, filed Feb 24, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ronald A Andrews | Director, Executive |
| William Annett | Director, Executive |
| Andy Arno | Director |
| Andrew Arno | Director |
| Don Bailey | Director |
| Jennifer Levin Carter | Director |
| Karen B. Chapman | Executive |
| Melinda Griffith | Director |
| Andrea James | Executive |
| Alfred Kingsley | Director |
| Andrew Last | Director |
| Mitch Levine | Executive |
| Mitchell Levine | Executive |
| James Liu | Executive |
| Kristine C. Mechem | Executive |
| Aditya Mohanty | Director |
| Albert Parker | Executive |
| Robert W. Peabody | Director, Executive |
| Cavan Redmond | Director |
| Joshua Riggs | Director, Executive |
| Douglas T Ross | Executive |
| Louis Silverman | Director |
| Russell Skibsted | Executive |
| Padmavathi Sundar | Executive |
| Joseph Wagner | Director, Executive |
| Michael West | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
15 Cushing
Irvine, CA, 92618
Irvine, CA, 92618